Concepedia

Andrew Getahun

AG

32

Publications

1.6K

Citations

23

H-Index

1998

Active since

Affiliations

University of Colorado Denver(Current)

National Jewish Health

Uppsala University

University of Colorado Anschutz Medical Campus

Colorado State University

Andrew Getahun is an author at University of Colorado Denver specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

1998–2023

32

Publications

32

Monophosphorylation of CD79a and CD79b ITAM Motifs Initiates a SHIP-1 Phosphatase-Mediated Inhibitory Signaling Cascade Required for B Cell Anergy

Shannon O’Neill, Andrew Getahun, Stephen B. Gauld et al. · Immunity · 2011 · 162 citations · Full text

, , +8

High-efficiency RNA-based reprogramming of human primary fibroblasts

Igor Kogut, Sandra M. McCarthy, M. Pavlova et al. · Nature Communications · 2018 · 160 citations · Full text

IgE Enhances Antibody and T Cell Responses In Vivo via CD23+ B Cells

Andrew Getahun, Fredrik Hjelm, Birgitta Heyman · The Journal of Immunology · 2005 · 101 citations · Full text

Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells

Andrew Getahun, Nicole A. Beavers, Sandy Larson et al. · The Journal of Experimental Medicine · 2016 · 101 citations · Full text

IgG2a-Mediated Enhancement of Antibody and T Cell Responses and Its Relation to Inhibitory and Activating Fcγ Receptors

Andrew Getahun, Jörgen Dahlström, Sara Wernersson et al. · The Journal of Immunology · 2004 · 91 citations · Full text

Rows per page

1–5 of 32